enolate onto the dihydroimidazolium function. Using dimethyl
ethynedicarboxylate (CH2Cl2 20 1C, 72 h), where no proton
shift in the conjugate adduct is possible, six-membered adduct
15 was observed in low yield (5%). The unexpected structure
of 15 was supported by, for example, methine proton signals at
dH 7.8 and dC 147 showing an sp2 methine carbon atom, and
implying that the initial 1,4-cycloadduct has ring-opened and
the pendant amino function reclosed onto the alternative
pyridinium ion C-2 position.9
Scheme 5 Reagent: i, (E)-MeO2CHQCHCO2Me, N–R maleimide
added slowly, CH2Cl2 20 1C, 72 h.
We have demonstrated a novel conjugate addition-proton
transfer protocol for formation of dihydroimidazolium ylides,
and their 2 : 1 or 1 : 1 : 1 adducts with suitable dipolarophiles.
The cycloadducts are of value as building blocks towards
heterocyclic molecules of biological potential. Although some
yields are moderate, the cascade rapidly generates complexity,
with three new bonds and two new rings, so has good utility.
We acknowledge studentship support from Loughborough
University (M. S-A.) and The Open University (X. Z.), and the
EPSRC Mass Spectrometry Service Centre (Swansea) for high
resolution MS data, and thank STFC for access to station
16.2SMX of the SRS at Daresbury.
Fig. 3 X-Ray crystal structure of 1 : 1 : 1 cycloadduct 8a, stereochemistry
inverted from refined coordinates to correlate with Scheme 5. There are
two enantiomorphous molecules in the asymmetric unit and the space
group is centrosymmetric.
(CH2Cl2 reflux, 72 h) afforded 2 : 1 adduct 11a as the only
identifiable product (52%) (Scheme 6). This stereochemistry,
supported by spectroscopic data, is as predicted by the transition
state model. The chiral centre in 10 confers optical activity on
the adduct; cycloaddition occurs on the face of the formed
dipole opposite to the phenyl group as expected from our
earlier reports.3 N-Phenylmaleimide provided 2 : 1 adduct 11b
(73%), structure assigned by NMR methods in comparison to 11a.
Methyl or ethyl fumarate esters as acceptors and dipolarophiles led
to the 2 : 1 adducts 12a,b (33, 48%, respectively) in a much slower
reaction.
Notes and references
z We have to date been unable to isolate 1 : 1 : 1 adducts from reactions
of dihydroimidazole 1 with a doubly activated alkene as Michael
acceptor and a mono-activated alkene as dipolarophile.
We have established that the acceptor/dipolarophile alkene
must carry two electron-withdrawing groups by attempting
reactions of 1 with mono-activated alkenes such as propenoate
esters and 2-phenylnitroethene, when no pyrrolidine forma-
tion was observed.z These experiments did nevertheless
provide support for our proposed mechanistic sequence. In
the case of 2-phenylnitroethene (CH2Cl2 20 1C, 24h) the initial
conjugate adduct did not undergo proton transfer (which
would now be unfavourable) and behaved as a 1,4-dipole to
afford six-membered adducts 13 in low yield (3%) along with
the ring-opened derivative 14 (36%) of a diastereomeric
cycloadduct. This cycloaddition is rationalised as a two-step
process: a second conjugate addition and closure of the generated
1 For example: F. Bellina and R. Rossi, Tetrahedron, 2006, 62, 7213;
I. Coldham and R. Hufton, Chem. Rev., 2005, 105, 2765;
D. O’Hagan, Nat. Prod. Rep., 2000, 17, 435.
2 For example: G. Pandey, P. Banerjee and S. R. Gadre, Chem. Rev.,
2006, 106, 4484; L. M. Harwood and R. J. Vickers, in Synthetic
Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Hetero-
cycles and Natural Products, ed. A. Padwa and W. H. Pearson,
Wiley-Interscience, Hoboken, 2003, p. 169.
3 Leading references: (a) R. C. F. Jones, K. J. Howard, J. S. Snaith,
A. J. Blake, W.-S. Li and P. J. Steel, Org. Biomol. Chem., 2011,
9, 297; (b) R. C. F. Jones, S. Rafiq, M. R. J. Elsegood, V. McKee
and M. J. Slater, Chem.–Asian J., 2010, 5, 461; (c) P. M. J. Lory,
R. C. F. Jones, J. N. Iley, S. J. Coles and M. B. Hursthouse, Org.
Biomol. Chem., 2006, 4, 3155; (d) R. C. F. Jones, K. J. Howard,
J. R. Nichols and J. S. Snaith, J. Chem. Soc., Perkin Trans. 1, 1998,
2061.
4 R. C. F. Jones, J. N. Iley, M. Sanchis-Amat, X. Zhang and
M. R. J. Elsegood, Tetrahedron Lett., 2009, 50, 3577.
5 For recent references: P. Prasanna, K. Balamurugan, S. Perumal,
P. Yogeeswari and D. Sriram, Eur. J. Med. Chem., 2010, 45, 5653;
M.-N. Cheng, H. Wang and L.-Z. Gong, Org. Lett., 2011, 13, 2418.
6 For example: C. L. Bagwell, M. G. Moloney and M. Yaqoob,
Bioorg. Med. Chem. Lett., 2010, 20, 2090; C. J. Hayes, A. E.
Sherlock, M. P. Green, Claire Wilson, A. J. Blake, M. D. Selby
and J. C. Prodger, J. Org. Chem., 2008, 73, 2041.
7 Cf. L. Zirngibl, Tetrahedron Lett., 1971, 12, 4189; L. Zirngibl,
T. Wagner-Jauregg and E. Pretsch, Tetrahedron, 1971, 27, 2203.
8 For example: V. Majce, M. Kocevar and S. Polanc, Tetrahedron
Lett., 2011, 52, 3287.
9 Cf. P. J. Abbott, R. M. Acheson, M. Y. Kornilov and J. K. Stubbs,
J. Chem. Soc., Perkin Trans. 1, 1975, 2322.
Scheme 6 Reagents: i, N–R maleimide, CH2Cl2 reflux, 72 h; ii,
(E)-RO2CHQCHCO2R, CH2Cl2 reflux, 17 days.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 7965–7967 7967